Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.73 EUR | -0.73% | -1.44% | +16.67% |
04-22 | Cellularline buys 7,000 of its own ordinary shares | AN |
04-15 | Cellularline updates on its buyback program | AN |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 143.1 | 98.58 | 86.79 | 61.87 | 49.94 | 57.39 | - |
Enterprise Value (EV) 1 | 167.7 | 147.6 | 124.2 | 102.3 | 85.32 | 91.99 | 84.89 |
P/E ratio | 8.05 x | 7.34 x | -23.4 x | - | - | - | - |
Yield | 4.55% | 6.5% | 3.6% | - | - | 3.19% | 3.19% |
Capitalization / Revenue | 1.02 x | 0.94 x | 0.78 x | 0.45 x | 0.31 x | 0.33 x | 0.3 x |
EV / Revenue | 1.19 x | 1.41 x | 1.12 x | 0.74 x | 0.54 x | 0.53 x | 0.44 x |
EV / EBITDA | 5.07 x | 9.77 x | 7.7 x | 6.15 x | 4.11 x | 3.62 x | 2.8 x |
EV / FCF | 11 x | 130 x | 8.82 x | -202 x | 10.5 x | 21.9 x | 8.16 x |
FCF Yield | 9.05% | 0.77% | 11.3% | -0.49% | 9.56% | 4.57% | 12.3% |
Price to Book | 0.72 x | 0.49 x | 0.44 x | 0.52 x | 0.38 x | 0.43 x | 0.42 x |
Nbr of stocks (in thousands) | 20,443 | 20,037 | 20,232 | 20,830 | 21,341 | 21,023 | - |
Reference price 2 | 7.000 | 4.920 | 4.290 | 2.970 | 2.340 | 2.730 | 2.730 |
Announcement Date | 20-03-11 | 21-03-19 | 22-03-17 | 23-03-15 | 24-03-13 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | 140.4 | 104.5 | 110.6 | 137.6 | 158.6 | 175 | 192 |
EBITDA 1 | 33.06 | 15.1 | 16.12 | 16.64 | 20.76 | 25.38 | 30.34 |
EBIT 1 | 23.35 | 10.44 | 10.74 | 10.25 | 14.02 | 18.58 | 23.34 |
Operating Margin | 16.63% | 9.98% | 9.71% | 7.45% | 8.83% | 10.62% | 12.16% |
Earnings before Tax (EBT) 1 | 20.08 | -2.396 | -6.556 | -74.82 | 4.25 | 8.11 | 12.87 |
Net income 1 | 18.21 | 13.9 | -3.846 | -75.17 | 3.595 | 5.68 | 9.01 |
Net margin | 12.97% | 13.3% | -3.48% | -54.61% | 2.27% | 3.25% | 4.69% |
EPS | 0.8699 | 0.6701 | -0.1834 | - | - | - | - |
Free Cash Flow 1 | 15.18 | 1.136 | 14.08 | -0.506 | 8.154 | 4.2 | 10.4 |
FCF margin | 10.81% | 1.09% | 12.73% | -0.37% | 5.14% | 2.4% | 5.42% |
FCF Conversion (EBITDA) | 45.92% | 7.52% | 87.31% | - | 39.28% | 16.55% | 34.28% |
FCF Conversion (Net income) | 83.37% | 8.17% | - | - | 226.82% | 73.94% | 115.43% |
Dividend per Share 2 | 0.3186 | 0.3200 | 0.1545 | - | - | 0.0870 | 0.0870 |
Announcement Date | 20-03-11 | 21-03-19 | 22-03-17 | 23-03-15 | 24-03-13 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt 1 | 24.6 | 49 | 37.4 | 40.4 | 35.4 | 34.6 | 27.5 |
Net Cash position 1 | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 0.7428 x | 3.244 x | 2.32 x | 2.428 x | 1.705 x | 1.363 x | 0.9064 x |
Free Cash Flow 1 | 15.2 | 1.14 | 14.1 | -0.51 | 8.15 | 4.2 | 10.4 |
ROE (net income / shareholders' equity) | 9.18% | 6.76% | 3.6% | -44.8% | 2.71% | 4.2% | 6.4% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | 9.670 | 10.00 | 9.800 | 5.700 | 6.160 | 6.300 | 6.500 |
Cash Flow per Share | 1.120 | 0.5400 | 0.9100 | 0.2400 | - | - | - |
Capex 1 | 8.31 | 10.2 | 5 | 5.4 | 4.89 | 3.5 | 3.5 |
Capex / Sales | 5.92% | 9.73% | 4.52% | 3.92% | 3.08% | 2% | 1.82% |
Announcement Date | 20-03-11 | 21-03-19 | 22-03-17 | 23-03-15 | 24-03-13 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.67% | 61.27M | |
-23.95% | 1.17B | |
-15.62% | 1.14B | |
+8.65% | 744M | |
-7.51% | 383M | |
-0.89% | 309M | |
+0.06% | 208M | |
0.00% | 205M | |
+12.07% | 87.88M | |
-13.54% | 59.83M |
- Stock Market
- Equities
- CELL Stock
- Financials Cellularline S.p.A.